Trials / Unknown
UnknownNCT05231447
Birth Defect Registry in South West Region of France
Registry of Congenital Anomalies in Nouvelle-Aquitaine, France
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,000 (estimated)
- Sponsor
- University Hospital, Bordeaux · Academic / Other
- Sex
- All
- Age
- 1 Minute – 1 Year
- Healthy volunteers
- Not accepted
Summary
Regional population-based registry for the epidemiological surveillance of congenital anomalies
Detailed description
By systematically collecting data on congenital anomalies, the registry aims to : * provide essential epidemiological information on congenital anomalies in South West of France * Promote etiological research concerning congenital anomalies, particularly with regard to environmental risk factors (systematic questionnaire) and other teratogenic agents (drugs) * act as an information and resource center for the population, health professionals and managers regarding clusters or exposures or risk factors of concern. * evaluate the effectiveness of primary prevention * assess the impact of developments in prenatal screening * study the fate of children with congenital anomalies, particularly in terms of neurodevelopment, through the creation of cohorts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Environmental survey | Exposure to environmental factors, drugs or individual toxicity during the periconceptional period and at the beginning of the pregnancy will be investigated by means of a questionnaire administered to the parents. This questionnaire, drawn up by the "Aquitaine Reproduction Enfance Maternité et Impact Santé-environnement" (ARTEMIS) centre and completed by both members of the couple, will constitute an initial assessment that will make it possible to collect environmental exposures for the parents of cases identified by the register. |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2025-03-01
- Completion
- 2025-03-01
- First posted
- 2022-02-09
- Last updated
- 2022-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05231447. Inclusion in this directory is not an endorsement.